Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting

被引:34
作者
Chacon, Lucia [1 ]
Luisa Mateos, Maria [2 ]
Holguin, Africa [1 ]
机构
[1] Raman y Cajal Hlth Res Inst IRYCIS, Mol Epidemiol Lab, Microbiol Dept, Madrid, Spain
[2] Hosp Ramon & Cajal, Microbiol Dept, Madrid, Spain
关键词
HIV; Diagnostic test; Architect; S/CO; False positive result; AG/AB COMBO ASSAY; BLOOD-DONORS; INFECTION;
D O I
10.1016/j.jcv.2017.04.014
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Despite the high specificity of fourth-generation enzyme immunoassays (4th-gen-EIA) for screening during HIV diagnosis, their positive predictive value is low in populations with low HIV prevalence. Thus, screening should be optimized to reduce false positive results. Objectives: The influence of sample cutoff (S/CO) values by a 4th-gen-EIA with the false positive rate during the routine HIV diagnosis in a low HIV prevalence population was evaluated. Study design: A total of 30,201 sera were tested for HIV diagnosis using Abbott Architect (R) HIV-Ag/Ab-Combo 4th-gen-EIA at a hospital in Spain during 17 months. Architect S/CO values were recorded, comparing the HIV-1 positive results following Architect interpretation (S/CO >= 1) with the final HIV-1 diagnosis by confirmatory tests (line immunoassay, LIA and/or nucleic acid test, NAT). ROC curve was also performed. Results: Among the 30,201 HIV performed tests, 256 (0.85%) were positive according to Architect interpretation (S/CO >= 1) but only 229 (0.76%) were definitively HIV-1 positive after LIA and/or NAT. Thus, 27 (10.5%) of 256 samples with S/CO >= 1 by Architect were false positive diagnose. The false positive rate decreased when the S/CO ratio increased. All 19 samples with S/CO <= 10 were false positives and all 220 with S/CO > 50 true HIV-positives. The optimal S/CO cutoff value provided by ROC curves was 32.7. No false negative results were found. Conclusions: We show that very low S/CO values during HIV-1 screening using Architect can result HIV negative after confirmation by LIA and NAT. The false positive rate is reduced when S/CO increases.
引用
收藏
页码:11 / 13
页数:3
相关论文
共 19 条
  • [1] The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing
    Acar, Ali
    Kemahli, Sabri
    Altunay, Husnu
    Kosan, Erdogan
    Oncul, Oral
    Gorenek, Levent
    Cavuslu, Saban
    [J]. TRANSFUSION MEDICINE, 2010, 20 (03) : 152 - 159
  • [2] A cure for HIV: what will it take?
    Ananworanich, Jintanat
    Mellors, John W.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2015, 10 (01) : 1 - 3
  • [3] [Anonymous], 2016, CONGUID UANT DRU
  • [4] [Anonymous], 2014, Laboratory testing for the diagnosis of HIV infection: Updated recommendations, DOI 10.15620/cdc.23447
  • [5] [Anonymous], 2015, AR VIG VIH COMP RIES
  • [6] When good news is bad news: psychological impact of false positive diagnosis of HIV
    Bhattacharya, Rahul
    Barton, Simon
    Catalan, Jose
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2008, 20 (05): : 560 - 564
  • [7] Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay
    Chavez, Pollyanna
    Wesolowski, Laura
    Patel, Pragna
    Delaney, Kevin
    Owen, S. Michele
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2011, 52 : S51 - S55
  • [8] Crowell TA, 2015, J VIRUS ERAD, V1, P72
  • [9] Evaluation of the clinical effectiveness of HIV antigen/antibody screening using a chemiluminescence microparticle immunoassay
    Cui, Chanjuan
    Liu, Ping
    Feng, Zhenru
    Xin, Ruolei
    Yan, Cunling
    Li, Zhiyan
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2015, 214 : 33 - 36
  • [10] Real-life evaluation of a human immunodeficiency virus screening algorithm using a single combined p24 antigen-antibody assay
    Fanmi, A. N.
    Ramiere, C.
    Tardy, J. C.
    Andre, P.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (03) : 425 - 430